[Bushen Daozhuo Granules for type â
¢ prostatitis: A multicenter randomized controlled clinical trial].
Zhonghua Nan Ke Xue
; 23(2): 164-168, 2017 Feb.
Article
en Zh
| MEDLINE
| ID: mdl-29658256
ABSTRACT
OBJECTIVE:
To study the safety and efficacy of Bushen Daozhuo Granules (BDG) in the treatment of type â ¢ prostatitis.METHODS:
This multiîcenter randomized controlled clinical trial included 478 patients with type â ¢ prostatitis, 290 in the trial group and 188 as controls, the former treated with BDG at 200 ml bid and the latter with tamsulosin hydrochloride sustainedîrelease capsules at 0.2 mg qd, both for 4 weeks. Before treatment, after 4 weeks of medication, and at 4 weeks after drug withdrawal, we obtained the NIH Chronic Prostatitis Symptom Index (NIHîCPSI) scores and compared the safety and effectiveness rate between the two groups of patients.RESULTS:
Compared with the baseline, the NIHîCPSI score was markedly decreased in the control group after 4 weeks of medication (21.42 ± 4.02 vs 15.67 ± 3.65, P < 0.05) but showed no statistically significant difference from that at 4 weeks after drug withdrawal (19.03 ± 3.86) (P>0.05), while the NIHîCPSI score in the trial group was remarkably lower than the baseline both after 4 weeks of medication and at 4 weeks after drug withdrawal (10.92 ± 2.06 and 12.91 ± 2.64 vs 21.58 ± 3.67, P < 0.05). The trial group exhibited both a higher rate of total effectiveness and safety than the control (P < 0.05).CONCLUSIONS:
BDG is safe and effective for the treatment of type â ¢ prostatitis.Palabras clave
Buscar en Google
Bases de datos:
MEDLINE
Medicinas Tradicionales:
Medicinas_tradicionales_de_asia
/
Medicina_china
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
Asunto principal:
Prostatitis
/
Medicamentos Herbarios Chinos
/
Agentes Urológicos
Tipo de estudio:
Clinical_trials
Idioma:
Zh
Revista:
Zhonghua Nan Ke Xue
Año:
2017
Tipo del documento:
Article
País de afiliación:
China